SCHEMBL7374754

SCHEMBL7374754

c1ccc(-c2ccc(OCCN3CCc4cc5c(cc4C3)OCO5)c3c2CCC3)nc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 5/20 0.48
NOS1 P29475 5/20 0.48
NOS2 P35228 5/20 0.48
ADRA2A P08913 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
ABCB1 P08183 5/20 0.38
ATM Q13315 2/20 0.37
POLB P06746 1/20 0.37
MAPT P10636 2/20 0.36
ABCC1 P33527 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
MAPK1 P28482 1/20 0.36
ABCG2 Q9UNQ0 1/20 0.35
PKM P14618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5833230 0.87 NOS3 (0.67) NOS3NOS1NOS2ABCB1ABCC1
SCHEMBL5833602 0.85 NOS3 (0.67) NOS3NOS1NOS2ABCB1ABCC1
SCHEMBL5833244 0.76 NOS3 (0.64) NOS3NOS1NOS2ABCB1ATM
SCHEMBL5833404 0.72 NOS3 (0.76) NOS3NOS1NOS2ATMPOLB
SCHEMBL29500447 0.66 KCNH2 (0.45) NOS3NOS1NOS2POLBMAPT
SCHEMBL22133123 0.66 KCNH2 (0.45) NOS3NOS1NOS2POLBMAPT
SCHEMBL5833606 0.65 NOS3 (1.00) NOS3NOS1NOS2
SCHEMBL5834287 0.65 NOS3 (1.00) NOS3NOS1NOS2
SCHEMBL9624316 0.65 GNRHR (0.45) ATMPOLBKDM4EPKM
SCHEMBL5833081 0.64 NOS3 (0.84) NOS3NOS1NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109556-A2 NEW PHARMACEUTICAL USES FOR NOS INHIBITORS Pfizer Products Inc. (US) 2001-06-27 EP disclosed
EP-1007520-A1 2-AMINOPYRIDINES CONTAINING FUSED RING SUBSTITUENTS AS NOS INHIBITORS Pfizer Products Inc. (US) 2000-06-14 EP disclosed
WO-2000009130-A2 NEW PHARMACEUTICAL USES FOR NOS INHIBITORS PFIZER PRODUCTS INC. (US) 2000-02-24 WO disclosed
WO-1999010339-A1 2-AMINOPYRIDINES CONTAINING FUSED RING SUBSTITUENTS AS NOS INHIBITORS PFIZER PRODUCTS INC. (US) 1999-03-04 WO disclosed